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delay dependence. Few studies have explored such a relationship in Continental 
Europe. Methods: We use data from the DEP-FR study. We ran ordered logisitic and 
heckman regressions. Results: We provide evidence: that there is a positive and 
significant correlation between cognitive, functional and behavioral declines and 
dependence on others, that an increase in dependence on others is associated with 
a decrease in informal care providers’ satisfaction, that there is a linear relationship 
between dependence on others and informal and formal care use. ConClusions: 
Our results provide two main dependence policies perspectives. First, public inter-
ventions should try to reduce dependence through its three main dimensions of 
dependence on others (cognitive, behavioral and functional), and not only focus 
on the functional dimension of dependence. Second, specific measures should be 
implemented to the release of informal caregivers’ burden, which increases with 
dependence on others.
PMH68
How well Do we UnDerstanD tHe econoMic BUrDen associateD 
witH DeMentia? a FocUs on trenDs in care HoMe costs anD FUtUre 
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objeCtives: The prevalence and economic burden of dementia is increasing, and 
in 2007 the UK government declared dementia a national priority. This research 
aims to evaluate trends in care home costs for dementia patients following this 
announcement, and to discuss the implications for the future economic burden 
of dementia. Methods: PubMed was searched for terms related to ‘cost’, ‘care 
homes’ and ‘dementia’. Horizon scanning was additionally performed for costs 
of care home data in the context of the wider economic burden of dementia. Only 
UK studies published after 2007 were considered, and information from a range of 
sources was assimilated to understand future implications for the economic burden 
of dementia. Results: Four relevant PubMed articles and an additional twelve 
publications from horizon scanning were identified. It was reported that two-thirds 
of care home patients have dementia and that accommodation costs represent the 
major contributor to the cost of dementia (41%). The average annual cost of a care 
room had risen from £25,953 in 2011 to £27,404 in 2012 and this was accompanied 
by a 3.9% deficit in local authority payment increases for care home residents from 
2010 to 2012. It is estimated that by 2043, more than double the current number of 
care home places will be required to match the increase in dementia prevalence, 
and the economic dependency ratio is expected to increase from 24% to 30% over 
the next 15 years. ConClusions: A considerable proportion of dementia patients 
are treated in care homes and, considering the disparity between the rising costs of 
care homes and funding increases, the burden borne by patients and their families 
is increasing. There is therefore an imminent need to develop cost-effective service 
provision for dementia patients; the new remit of NICE in social care may represent 
an important step towards this.
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objeCtives: Management of chronic nonmalignant pain (CNMP) is important in 
both primary care and rehabilitative medicine however, the relationships between 
CNMP and the diverse types of addiction and chemical dependency are often 
complex and clinically relevant. The objective of this pilot study was to examine 
the impact of the Functional Restoration and Pain Management (FRPM) Program 
on pain severity outcomes and controlled medication use among CNMP patients 
enrolled in the Texas Workers Compensation (TWC) benefit program. Methods: 
A retrospective cohort analysis of administrative claims and medical records data 
was conducted among TWC chronic pain patients enrolled in the FRPM Program 
receiving buprenorphine therapy. Prescription utilization patterns and pain severity 
outcomes during a 12-month observation period were examined. Eligible patients 
were ≥ 18 years of age, continuously enrolled as TWC beneficiaries, had a history 
of utilization of chronic pain medications at enrollment, placed on buprenorphine 
therapy, and received services through the FRPM program within the observation 
period defined as date from patient entry into the program to 12 months post-
enrollment. Results: The mean age of eligible participants (N= 18) enrolled in the 
pilot study was 49.6 years ±9.5. A majority of patients were male (61%), white (61%), 
had a chronic pain lumbar diagnosis (45%), depression comorbidity (78%), and a 
substance abuse disorder (39%). Overall, patients showed a significant reduction in 
pain scores (p= 0.032) at month 12 compared to baseline. For controlled medication 
utilization, there was a significant difference in narcotic pain medication use reduc-
tion in Hispanics/Latinos (p= 0.033) compared to other racial/ethnic groups (i.e., 
Whites and African-Americans) at month 12 compared to baseline. ConClusions: 
Though a pilot study, the results suggest that the FRPM program has the potential 
of improving health outcomes of patients with chronic pain, while reducing their 
use of controlled medications. A larger follow-up study is needed to validate and 
expand on these preliminary findings.
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objeCtives: To examine caregiver reported impact of ASD on family as compared 
to impact of other developmental disabilities (DD) and mental health conditions 
(MHC) on family. Methods: A cross-sectional study using 2009-2010 National 
Survey of Children with Special Health Care Needs on caregivers of children aged 
3-17 years with either ASD, DD, MHC, or both DD and MHC diagnosis (N = 18,136) 
infrequent (4% diabetes and 3% neurological disorders). The most common depot 
antipsychotics prescribed were zuclopentixol (32%), perphenazine (28%) and risp-
eridone LAI (19%). These were prescribed primarily by psychiatrists (85%). Median 
persistence to depot treatment was 195 days. ConClusions: To our knowledge, 
this is the first large database study conducted in Sweden aiming at describing 
the patients’ characteristics and treatment patterns of schizophrenic patients 
treated with depot antipsychotics. It is notable that the current sub-population of 
schizophrenic patients treated with depot does not show substantial psychiatric 
and somatic co-morbidities, possibly due to under-diagnosing of co-morbidities, 
especially somatic diseases, by psychiatrists.
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objeCtives: To examine the economic burden and health care utilizations of 
schizophrenia in the U.S. veteran population. Methods: A retrospective database 
analysis was performed using the Veterans Health Administration (VHA) Medical 
SAS datasets from October 1, 2008 to September 30, 2012. Patients diagnosed with 
schizophrenia were identified using International Classification of Disease 9thRevi-
sion Clinical Modification (ICD-9-CM) diagnosis codes 295.xx, and the first diagnosis 
date was designated as the index date. A group of patients without schizophrenia 
of the same age, region, gender and index year were identified and matched by 
baseline Charlson Comorbidity Index (CCI) as the comparison group. Patients in 
both groups were required to be at least 18 years old and have continuous medical 
and pharmacy benefits 1 year pre- and 1 year post-index date. One-to-one propen-
sity score matching was used to compare health care costs and utilizations during 
the follow-up period between the schizophrenia and comparison group patients, 
adjusted for baseline demographic and clinical characteristics. Results: A total of 
171,086 eligible patients were identified for the schizophrenia and control cohorts. 
After 1:1 matching, a total of 70,045 patients were matched from each cohort with 
well-balanced baseline characteristics. Patients diagnosed with schizophrenia had 
significantly higher health care utilization in inpatient (18.12% vs. 2.30%, p< 0.01), 
emergency room (19.67% vs. 6.46%, p< 0.01), office (98.32% vs. 53.26%, p< 0.01), and 
outpatient visits (98.53% vs. 54.16%, p< 0.01). Higher health care utilizations trans-
lated into higher costs for schizophrenic patients including inpatient ($7,228 vs. 
$613, p< 0.01), pharmacy ($1,012 vs. $343, p< 0.01), outpatient ($3,998 vs. $1,302, 
p< 0.01), and total costs ($12,238 vs. $2,260, p< 0.01) relative to patients in the com-
parison group. ConClusions: Schizophrenic patients were associated with a sub-
stantial economic burden compared to their matched controls.
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objeCtives: To compare health care resource utilization (HRU) among schizo-
phrenic patients in the United States by the type of health insurance and estimate 
the annual expenditures. Methods: The 2007 National Health and Interview 
Survey (NHIS) data were used for this study (150 schizophrenia cases). Multivariate 
regression was conducted to compare HRU (hospitalizations, physician visits, ER vis-
its) by type of health of insurance (any private, public only, and none). Additionally, 
2008 Medical Expenditure Panel Survey (MEPS) data were linked with the NHIS data 
(29 of the NHIS cases). Means, SE and 95% confidence intervals of prescription and 
total health care annual expenditures were calculated for schizophrenic patients 
by insurance type. Results: Multivariate analysis indicated a significant associa-
tion between the number of hospitalizations, physician visits and ER visits over 
12 months and any private insurance (β = -2.06, SE= 0.84, p= 0.01; -19.69, 8.92, 0.03; 
-22.35, 9.55, 0.02, respectively) compared to no insurance (referent). These same 
associations were not significant for the public only insurance (-0.30, 0.44, 0.16; 
-5.89, 3.91, 0.13; -7.72, 4.09, 0.06, respectively). Mean, SE [95% confidence interval] 
prescription expenditures for schizophrenic patients are similar between private 
insurance holders ($737, 215.3 [312.3-1161.6]) and those without insurance ($718, 
237.0 [249.7-1186.3]), but were higher for public insurance holders ($3781, 897.2 
[2008.1-5553.0]). Mean total health care expenditures for schizophrenic patients are 
similar between private insurance holders ($4000, 1382.4 [1273.9-6726.7]) and those 
without insurance ($4318, 2215.4 [0-8696.6]), but were higher for public insurance 
holders ($12,584, 2452.2 [7739.6-17,428.8]). ConClusions: Private insurance HRU 
for schizophrenic patients is lower than public only insurance holders, followed 
by those without insurance. Seemingly contradictory, a higher expenditure among 
public insurance holders was observed. This observation could be the result of the 
more severe schizophrenic cases having only public insurance. Caution should be 
employed in the use of the expenditure calculations due to the small numbers of 
patients.
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objeCtives: The increasing economic importance of dependence on others in the 
elderly population is a major problem in Europe. This problem is very concern-
ing for patients with Alzheimer’s disease, who heavily rely on informal caregivers’ 
assistance. Exploring the relationship between patients’ dependence on others 
and care expenditures is very important when planning future resources for the 
elderly and for predicting the economic consequences of interventions which may 
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objeCtives: To describe medication use patterns and adherence rates for 
schizophrenia patients after initiating antipsychotic treatment in Tianjin, 
China. Methods: Data were extracted from the Tianjin Urban Employee Basic 
Medical Insurance database (2008-2010). Adult patients with a schizophrenia 
diagnosis, newly initiating or restarting antipsychotics (no antipsychotics during 
previous 90 days) with 12-month continuous enrollment after their first observed 
antipsychotic prescription were included. Patients’ medication prescribing patterns 
and antipsychotic adherence are described. Results: A total of 1216 patients were 
identified, with a mean (SD) age of 51.43 (12.48) years, 54.11% female. 83.14% of 
patients initiated with one antipsychotic and 16.86% with ≥ 2 antipsychotics. 37.99% 
of patients were initiated on typical antipsychotics, 52.06% on atypicals, and 9.95% 
on both. A higher portion of typical initiators were co-prescribed antianxiety and 
anticholinergic medications than atypical starters (both p< 0.001). During the follow-
ing 12 months, the majority of patients remained on medications from their initial 
antipsychotic class (80.74% of typical initiators vs. 86.41% of atypical initiators) or 
the same medication (66.45% of typical initiators vs. 70.93% of atypical initiators). 
More typical initiators switched to, or augmented with, atypical antipsychotics than 
atypical initiators to/with typical antipsychotics (19.26% vs. 13.59%, P= 0.011). During 
the following 3, 6 and 12 months, antipsychotic continuation rates (≤ 30 days gap) 
were 50.33%, 23.60%, and 8.88%, respectively. Medication Possession Ratios were low, 
with means (SD) of 0.58 (0.32), 0.44 (0.30), and 0.34 (0.27) for the 3, 6 and 12 months, 
respectively. ConClusions: More individuals with schizophrenia were treated 
with atypicals rather than typical antipsychotics. The majority of patients tended 
to stay with one antipsychotic drug class or the same medication. Patients’ adher-
ence to prescribed antipsychotics was low. This study highlights the importance 
of selecting an effective medication when starting antipsychotic therapy in China. 
However much could be done to improve treatment adherence.
MUscUlar-sKeletal DisorDers – clinical outcomes studies
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objeCtives: 1) To determine the minimal important change (MID) of indirect util-
ity score for patients with osteoarthritis (OA) over 3-year follow up, and 2)Estimate 
the impact of comorbidity for patients reaching the MID. Methods: A total of 878 
patients with symptomatic knee or/and hip OA of KHOALA cohort were included. 
Comorbidity were assessed by Functional Comorbidity Index (FCI). Utility score 
was assessed using SF-6D, and limitation in activities by WOMAC function score 
(0-100,0 is better), at baseline and 3-year. The MID of utility was assessed using 
standard error of measurement (SEM). According to MID, patients were classified as 
negative/positive change or unchanged. Two separate multinomial logistic models 
were fitted to determine predictors of positive or negative change over the MID 
threshold. Both models included sociodemographic characteristics and the mean 
difference of WOMAC score between baseline and 3-year. Results: A total of 650 
OA patients completed the questionnaire at both times. The mean (SD) utility was 
0.664 (±0.110) at baseline and 0.667 (±0.110) at 3-year. Patients have on average 2.5 
(±1.94) comorbidities and a signifcant (p< .0001) decrease of the WOMAC function 
score at 3-year. The MID of SF-6D utility score was 0.067: 147 patients classified with 
negative and 156 with a positive change. In the first model including the number 
of comorbidities, patients with a decrease of the WOMAC function score had an 
increased utility (OR= 0.95; p< .0001). In the second model, patients with pneumo-
logic (OR= 1.88; p= 0.03) or neurologic (OR= 2.73;p= 0.047) disease were likely to have 
improved utility, while patients having a psychiatric disease were less likely to have 
an improvement (OR= 0.54;p= 0.029). ConClusions: According to MID, about half 
of patients had a positive or negative change in their utility score. Compared to 
functional severity of OA, comorbidities have a relatively marginal impact on indi-
rect utility score. This suggests that clinically, considering the functional severity 
of OA remains a first priority.
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objeCtives: Rheumatoid arthritis (RA) is a chronic, systemic disease associated 
with comorbidities and extra-articular manifestations (EAM) . The main objective 
of the study was to estimate the frequency and impact of comorbidities and EAM in 
well-defined RA patients. Methods: A prospective study was conducted at a ter-
tiary care hospital between the years 2009 & 2012. Patients (age ≥ 18 years) with RA, 
fulfilling the revised criteria of the American college of rheumatology (1987 & 2010), 
were enrolled in the study. Standard clinical, laboratory and radiological measures 
of RA and details of comorbidities and EAM were recorded using patient hospital 
records. Results: Of 602 RA patients, 481 (79.9%) females and 121 (20.1%) males 
were present. Mean age of 47.57±12.78 years, mean disease duration of 4.52±4.75 
was conducted. Family impact was assessed as: Financial burden, Employment 
Burden, and Time-related burden. Binary and multinomial logistic regressions 
were conducted to compare likelihood of adverse family impact across ASD, DD 
without ASD, MHC without ASD, and DD and MHC without ASD, after adjust-
ing for socio-demographics, number of special children in the household, child’s 
functional ability, and presence of a physical condition. Results: Majority of 
the sample were older children (6-17 years), Whites, caregivers with ≥ 200% FPL 
income and greater than high school education. Sixteen percent (n= 2,801) of the 
caregivers had a child with an ASD diagnosis. Caregivers of children with ASD 
were more likely to have financial burden than caregivers of children with DD 
(AOR= 1.45, 95% CI= 1.10-1.91) and MHC (AOR= 1.59, 95% CI= 1.33-1.91). There were 
no significant differences in financial burden reports between caregivers of chil-
dren with ASD and those with both DD and MHC. Caregivers of children with ASD 
were also more likely to leave a job (employment), as compared to caregivers of 
children with DD (AOR= 1.57, 95% CI= 1.23-2.00), MHC (AOR= 3.06, 95% CI= 2.51-3.74), 
or both (AOR= 1.73, 95% CI= 1.36-2.20). Caregivers of children with ASD were more 
likely to report time-related burden as compared to caregivers of children with 
MHC (AOR= 2.87, 95% CI= 2.18-3.78) and DD and MHC (AOR= 1.80, 95% CI= 1.32-
2.44). ConClusions: Caregivers of children with ASD are more likely to report 
an adverse family impact as compared to caregivers of children with DD, MHC, 
or both.
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objeCtives: With increasing prevalence of dementia worldwide the interest in the 
dementia burden and impact on the health care system is rising. Yet comprehensive 
information about long-term needs and patterns of care of dementia patients and 
informal caregivers is scarce. Dementia specific registries provide an opportunity 
to investigate these aspects by long-term-data analysis. However, so far no inter-
national standards exist for developing a dementia registry. Methods: An inter-
disciplinary team (psychiatry, public health, psychology, medical sociology, health 
economics and gerontology) established a registry structure in 2012. In the concep-
tion phase, existing registries, studies of dementia and best practice scenarios were 
identified. Features were combined in our concept and inclusion criteria, time for 
follow-up, fields of particular relevance and instruments were determined. A ques-
tionnaire was built and tested in exemplar sites. Results: The pilot study started 
with prospective interviews in January 2013 to evaluate the concept. The inclusion 
criterion is a dementia diagnosis according to ICD-10. Patients are recruited from 
the regional memory clinic during the process of diagnosis. Patient drop outs occur 
after initial inclusion because of other ensured diagnosis such as depression. Both 
patients and caregivers are interviewed separately with internationally approved 
valid instruments. The follow-up will take place after 6, 12 months and annually 
until death or loss to follow-up. ConClusions: Existing dementia registries are 
very rare and heterogeneous in their structure, with currently no standards on 
quality indicators and processes. However, the complexity of dementia requires a 
sophisticated organizational structure for covering all aspects of dementia. Despite 
the challenges, our dementia registry structure provides essential, comprehensive 
and long-term information about the dementia care setting. The research is funded 
by the European Commission, ICT FP7, project ID 287509.
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objeCtives: There is an increasing demand for medication reviews to improve 
the quality of prescribing for patients with chronic illness such as psychiatric 
patients. Traditionally, this has been undertaken by physicians. Pharmacists have 
also proven to be a resource in this field but registered nurses are the health profes-
sionals spending most time directly with the patient and very few studies inves-
tigate nurses’ role and potential in improving the appropriateness of medication. 
Therefore, the objective of this study is to investigate the effect of educating nurses 
in general pharmacology and conducting systematic medication reviews using 
computer based screening. The effect is evaluated in a controlled interventional 
study. Methods: An interventional study including 2 acute psychiatric wards. In 
one ward nurses’ will receive pharmacological training and the other ward will func-
tion as a control. The nurses will perform approximately 250 medication reviews 
followed by medication reviews performed by pharmacologists. Primary outcomes 
are the respective frequencies, types and severity of potential inappropriate pre-
scriptions identified by the nurses and pharmacologists and an estimation of the 
interratervariability between the two professions. Results: The hypothesis is that 
nurse-led medication reviews will reduce potential inappropriate prescribing and 
that training will increase nurses’ ability to identify and report potential inappropri-
ate prescribing. It is assumed that this intervention, in addition to a more appropri-
ate prescribing, will lead to a reduction in length of hospitalization for psychiatric 
patients. ConClusions: The perspective for this study is to add knowledge about 
frequency, types and potential severity of potential inappropriate prescribing for 
psychiatric patients. The study will contribute with information regarding the effect 
of pharmacological training of nurses and possibly improve medication safety for 
psychiatric patients. Results from this study could serve as evidence, when hospital 
management makes decisions on how to accede the need for medication reviews 
as part of an ongoing accreditation process.
